An adverse events potential costs analysis based on Drug Programs in Poland. Dermatology focus
, , , , e
03 mar 2015
INFORMAZIONI SU QUESTO ARTICOLO
Pubblicato online: 03 mar 2015
Pagine: 183 - 186
Ricevuto: 09 ott 2014
Accettato: 03 nov 2014
DOI: https://doi.org/10.1515/cipms-2015-0012
Parole chiave
© 2015
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Szkultecka-Debek, Monika
Drozd, Mariola
Kiepurska, Nina
Janowska, Agnieszka
Paprzycki, Piotr
Paluchowska, Beata